Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multiple Dose Study of CK-2127107 in Two Ascending Dose Cohorts of Patients with Spinal Muscular Atrophy (SMA)
Trial ID or NCT#
To study the pharmacodynamics, safety, tolerability and pharmacokinetics of the study medication, CK-2127107, in patients with SMA.
Ana Tesi-Rocha, MD
Contact us to find out if this trial is right for you.
About this Clinical Trial
Your Message Will Go ToShirley Paulose
Go Back To The Trial